Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.13 - $0.46 $24,380 - $86,270
-187,545 Reduced 94.34%
11,242 $2,000
Q4 2021

Feb 14, 2022

BUY
$0.54 - $2.51 $72,545 - $337,200
134,343 Added 208.46%
198,787 $107,000
Q3 2021

Nov 15, 2021

BUY
$1.54 - $3.04 $99,243 - $195,909
64,444 New
64,444 $109,000

About Aditxt, Inc.


  • Ticker ADTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,161,130
  • Market Cap $749K
  • Description
  • Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...
More about ADTX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.